Skip to content

CorMedix CRMD Gross Profit

Discontinued — last reported Q1 '26

Gross Profit at other companies

Pfizer logo
PfizerPFE
$10.9B+0.3%
Merck & Co. logo
Merck & Co.MRK
$12.09B-0.2%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$184.8M+7.4%
ITG
Integer HoldingsITGR
$109.6M-8.9%
IAR
Integra LifeSciencesIART
$216.98M+11.6%
MiMedx Group logo
MiMedx GroupMDXG
$41.62M-41.9%

Other financials

Income statement

See full
Revenue$127.4M+226%
Operating income$63.7M+216%
Net income$38.6M+87.0%
EPS (diluted)$0.43+43.3%

Balance sheet

See full
Cash & equivalents$179.1M+170%
Total debt$4.3M+729%
Total equity$437.0M+280%
Total assets$815.6M+445%

Cash flow

See full
Operating cash flow$42.4M+115%
CapEx$729.0K+7,190%
Free cash flow$41.7M+111%

Valuation

See full
Market cap$605.65M-34.4%
P/E3.4×
P/S1.5×-9.6×

Profitability

See full
Gross margin91.9%-3.5pp
Operating margin48.4%
Net margin45.2%
FCF margin48.7%+38.8pp

Returns & leverage

See full
Return on equity65.6%
Debt / equity0.0×
Current ratio-1.2×

Where this comes from

Calculated from CorMedix’s reported figures.

The official record: CorMedix’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about CorMedix's gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CorMedix's gross profit?
CorMedix (CRMD) reported gross profit of $115.42M in Q1 2026.
How has CorMedix's gross profit changed year-over-year?
CorMedix's gross profit increased by 207.5% year-over-year, from $37.54M to $115.42M.
What is the long-term trend for CorMedix's gross profit?
Over 3 years (2021 to 2025), CorMedix's gross profit has grown at a 1803.3% compound annual growth rate (CAGR), from $42K to $289.57M.
What does gross profit mean?
Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.